Azathioprine News and Research

RSS
Azathioprine is an immunosupressant used in organ transplantation, autoimmune disease such as rheumatoid arthritis or inflammatory bowel disease such as Crohn's disease and ulcerative colitis. It is a pro-drug, converted in the body to the active metabolites 6-mercaptopurine and 6-thioinosinic acid.
UT Southwestern physicians outline the risks of pregnancy in women with rheumatic disease

UT Southwestern physicians outline the risks of pregnancy in women with rheumatic disease

Risk of severe COVID-19 in adults with immune-mediated inflammatory diseases and those on immune-modifying therapies

Risk of severe COVID-19 in adults with immune-mediated inflammatory diseases and those on immune-modifying therapies

Study compares heterologous and homologous third vaccination in kidney transplant recipients

Study compares heterologous and homologous third vaccination in kidney transplant recipients

Research supports the need for a 3rd mRNA COVID vaccine in patients taking immunosuppressants

Research supports the need for a 3rd mRNA COVID vaccine in patients taking immunosuppressants

Efficacy and safety of mRNA-based SARS-CoV-2 vaccination in immuno-compromised subjects

Efficacy and safety of mRNA-based SARS-CoV-2 vaccination in immuno-compromised subjects

Withdrawing steroid treatment found to boost SARS-CoV-2 vaccine-induced immunity in kidney transplant recipients

Withdrawing steroid treatment found to boost SARS-CoV-2 vaccine-induced immunity in kidney transplant recipients

Results of high-impact clinical trials could affect kidney-related medical care

Results of high-impact clinical trials could affect kidney-related medical care

Humoral and cellular response to COVID-19 vaccines in patients with IBD

Humoral and cellular response to COVID-19 vaccines in patients with IBD

SARS-CoV-2 inhibited by pyrimidine biosynthesis inhibitors in conjunction with nucleoside analogs

SARS-CoV-2 inhibited by pyrimidine biosynthesis inhibitors in conjunction with nucleoside analogs

Commonly-prescribed drug for IBD blunts COVID-19 vaccine response

Commonly-prescribed drug for IBD blunts COVID-19 vaccine response

Novel compound shows promise for ANCA-associated vasculitis

Novel compound shows promise for ANCA-associated vasculitis

Work in progress on medicine for treatment of ulcerative colitis

Work in progress on medicine for treatment of ulcerative colitis

Atopic dermatitis found to be highly prevalent among adults in the U.S.

Atopic dermatitis found to be highly prevalent among adults in the U.S.

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

FDA approves update to Rituxan label to include information on treatment of rare forms of vasculitis

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

FDA approves first oral medication for adults with moderately to severely active ulcerative colitis

Common drug for autoimmune disease may increase risk of myeloid neoplasms

Common drug for autoimmune disease may increase risk of myeloid neoplasms

Over-the-counter and prescription pain medications linked to drug-induced liver injury

Over-the-counter and prescription pain medications linked to drug-induced liver injury

Thymectomy confers benefit to MG patients who do not have chest tumor, study shows

Thymectomy confers benefit to MG patients who do not have chest tumor, study shows

Mycophenolate mofetil drug seems safe, effective in treating autoimmune hepatitis

Mycophenolate mofetil drug seems safe, effective in treating autoimmune hepatitis

Organ transplant recipients more likely to develop melanoma

Organ transplant recipients more likely to develop melanoma